{"id":88421,"date":"2019-03-05T16:44:11","date_gmt":"2019-03-06T00:44:11","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/03\/anti-cd47-antibody-trial-in-advanced-cancers-shows-treatment-appears-safe-well-tolerated"},"modified":"2019-03-05T16:44:11","modified_gmt":"2019-03-06T00:44:11","slug":"anti-cd47-antibody-trial-in-advanced-cancers-shows-treatment-appears-safe-well-tolerated","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/03\/anti-cd47-antibody-trial-in-advanced-cancers-shows-treatment-appears-safe-well-tolerated","title":{"rendered":"Anti-CD47 antibody trial in advanced cancers shows treatment appears safe, well-tolerated"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/anti-cd47-antibody-trial-in-advanced-cancers-shows-treatment-appears-safe-well-tolerated2.jpg\"><\/a><\/p>\n<p>An antibody against the \u201cdon\u2019t eat me\u201d signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned.<\/p>\n<p>Author Krista Conger Published on March 5, 2019 March 5, 2019.<\/p>\n<p><!-- Link: <a href=\"https:\/\/scopeblog.stanford.edu\/2019\/03\/05\/anti-cd47-antibody-trial-in-advanced-cancers-shows-treatment-appears-safe-well-tolerated\/\">https:\/\/scopeblog.stanford.edu\/2019\/03\/05\/anti-cd47-antibody...tolerated\/<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>An antibody against the \u201cdon\u2019t eat me\u201d signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned. Author Krista Conger Published on March 5, 2019 March 5, 2019.<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-88421","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/88421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=88421"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/88421\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=88421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=88421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=88421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}